If you are a shareholder in Momenta Pharmaceuticals Inc ... A stock with a beta greater than one is considered more sensitive to market-wide shocks compared to a stock that trades below the value of one. See our latest analysis for …
Craig A Wheeler , President of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) reportedly Sold 4,116 shares of the …
Investors in Momenta Pharmaceuticals, Inc. MNTA need to pay close attention to the stock based on moves in the options market lately. That is because the June 16 th, 2017 $13 Put had some of the highest implied volatility of all equity …
Nov 1 (Reuters) - Momenta Pharmaceuticals Inc -:Momenta Pharmaceuticals reports third quarter 2017 financial results and provides corporate update.Q3 revenue $24.1 million versus $29.1 million.Q3 revenue view $30.6 million -- Thomson …
About a month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have added about 5.8% in that time frame, outperforming the market. Will the recent positive trend continue leading up to the …
It has been about a month since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have lost about 9.7% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's …